Austrian Federal Office for Safety in Health Care

Recent updates

Here you can find new page content of the last 4 weeks.

News

Minoxipel Lösung zur Anwendung auf der Haut New

Recall | Medicines | 01/12/2022
Absence of the pipette in the package
Minoxipel Lösung zur Anwendung auf der Haut Read more
News

CHMP Meeting Highlights October 2022 New

CHMP Monthly News | 30/11/2022
Up-to-date information from the July 10.10.-13.10.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights October 2022 Read more
News

CHMP Meeting Highlights September 2022 New

CHMP Monthly News | 30/11/2022
Up-to-date information from the July 12.09-15.09.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
CHMP Meeting Highlights September 2022 Read more

Update: West Nile Virus (WNV) New

Safety warnings | Blood & Tissue | 29/11/2022
The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that 1 additional human WNV infection has been recorded in Germany.
Update: West Nile Virus (WNV) Read more

Tobramycin B. Braun 3 mg/ml Infusionslösung New

Recall | Medicines | 21/11/2022
Recall due to yellowish discolouration of the solution
Tobramycin B. Braun 3 mg/ml Infusionslösung Read more
News

Registration of an "Industry Single Point of Contact (i-SPOC)" for supply and availability at EMA

messages in brief | 17/11/2022
i-SPOC registration has been mandatory since September 2, 2022 and applies to all pharmaceutical companies with a centrally- or nationally-authorised human medicinal product in the EU.
Registration of an "Industry Single Point of Contact (i-SPOC)" for supply and availability at EMA Read more

Hexyon Injektionssuspension in einer Fertigspritze

Recall | Medicines | 17/11/2022
Batch recall due to possible product mix
Hexyon Injektionssuspension in einer Fertigspritze Read more

Information

COVID-19

Here you will find an overview of BASG information on prevention and treatment of COVID-19, as well as links to additional websites.

COVID-19 read more
Reporting to BASG

Reporting to BASG

The Federal Office relies on reports from consumers, health care professionals and companies for the continuous re-evaluation of the safety profile of medicinal products and medical devices.

Reporting to BASG read more
Online form for adverse reactions

Online form for adverse reactions

The reporting of suspected adverse reactions to vaccines and medicinal
products is possible using a patient-friendly online form.

Online form for adverse reactions read more
Austrian Medicinal Product Index

Austrian Medicinal Product Index

The medicinal products database contains all products authorised in Austria, including up-to-date product information leaflets and the summary of products characteristics.

Austrian Medicinal Product Index read more
Shortages

Shortages

Based on reports from pharmaceutical companies, BASG informs about current shortages.

Shortages read more

For Consumers

This is the subpage with information from the BASG directed to consumers (patients, their relatives and owners of animals).

read more

For Health Care Professionals

This is the subpage with information from the BASG directed to health care professionals (physicians, dentists, veterinarians, midwives and pharmacists).

read more

For Companies

This is the subpage with information by the BASG directed to companies producing, controlling or distributing medicinal products or medical devices.

read more

Market Surveillance

This is the subpage with the official announcements and public databases provided by the BASG as well as procedures for reporting to BASG.

read more